Shionogi
Karli Sekab, Ph.D., currently serves as Senior Medical Science Liaison at Shionogi Inc. since November 2023, previously holding the same title at InflaRx N.V. and Théa Pharma US. With extensive experience as a Medical Science Liaison at Kala Pharmaceuticals and Allergan, Karli's career also includes a project management role at iMD Medical Research Institute and a doctoral candidacy at McGill University, where a Ph.D. in Biomedical Engineering was earned. Teaching experience as a Teaching Assistant at McGill University complements a strong educational background that includes a Master's Degree in Biomedical Sciences from Université de Montréal and a Bachelor's Degree in Behavioural Neuroscience from Laurentian University.
This person is not in any teams
This person is not in any offices
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.